GlassScriptPhysician profile
Anna M Bruno
NPI 1275848434
$1,990.57
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $1,043 · 2023: $616 · 2024: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $243.70 | 2023-2024 | Austedo Xr |
| Genzyme Corporation | $240.18 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $222.37 | 2022 | |
| Novo Nordisk INC | $197.80 | 2022-2023 | Ozempic, Rybelsus |
| Sanofi Pasteur INC. | $124.97 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $123.99 | 2022 | |
| Xeris Pharmaceuticals, INC. | $121.87 | 2023 | Gvoke Hypopen |
| Dexcom, INC. | $117.43 | 2021 | |
| Neurelis, INC. | $109.25 | 2022 | |
| Gilead Sciences, INC. | $99.99 | 2022 | |
| Impel Pharmaceuticals INC. | $99.99 | 2022 | |
| Nevro Corp. | $98.49 | 2022 | |
| Itamar Medical INC | $98.22 | 2023 | Watchpatone |
| Boston Scientific Corporation | $70.72 | 2021 | |
| Intuitive Surgical, INC. | $21.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.